Internal Medicine, Nephrology · Tucson, AZ
NPI
1518963065
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2121 N Beverly Ave, Ste 105
Tucson, AZ, 85712
Phone (520) 327-6265
Groups this clinician bills Medicare through
Medicare paid, 2024
$202K
4,963 services
Medicare patients, 2024
514
Average age 76
Drug cost, 2024
$557K
4,907 prescriptions
Company payments, 2025
$496
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammed A Sikder was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 623 times for 282 patients. In total Mohammed A Sikder billed 4,963 services in 49 codes, and Medicare paid $202K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 623 | 282 | $11.75 | $7,321 |
| 99214 Office E&M - Established | Office | 586 | 269 | $84.02 | $49K |
| 80069 Clinical Chemistry | Office | 395 | 180 | $8.49 | $3,354 |
| 85027 Blood Count | Office | 319 | 156 | $6.32 | $2,017 |
| 83970 Clinical Chemistry | Office | 267 | 120 | $40.31 | $11K |
| 84550 Clinical Chemistry | Office | 246 | 116 | $4.41 | $1,086 |
| 36415 Venipuncture Blood Collection | Office | 227 | 126 | $5.88 | $1,335 |
| 99232 Hospital E&M - Subsequent | Facility | 220 | 88 | $55.20 | $12K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 199 | 57 | $48.27 | $9,606 |
| 99233 Hospital E&M - Subsequent | Facility | 188 | 87 | $86.16 | $16K |
| 84156 Clinical Chemistry | Office | 150 | 67 | $3.60 | $540 |
| 82570 Clinical Chemistry | Office | 147 | 65 | $5.08 | $747 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 131 | 57 | $36.95 | $4,840 |
| 90960 ESRD Related Services (not dialysis) | Office | 115 | 16 | $266.11 | $31K |
| 83735 Clinical Chemistry | Office | 85 | 47 | $6.57 | $558 |
By year: 2022 $191K for 4,282 services; 2023 $186K for 4,258 services; 2024 $202K for 4,963 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80069 Clinical Chemistry | 395 | 180 | $8.49 | $3,354 |
| 85027 Blood Count | 319 | 156 | $6.32 | $2,017 |
| 83970 Clinical Chemistry | 267 | 120 | $40.31 | $11K |
| 84550 Clinical Chemistry | 246 | 116 | $4.41 | $1,086 |
| 36415 Venipuncture Blood Collection | 227 | 126 | $5.88 | $1,335 |
| 84156 Clinical Chemistry | 150 | 67 | $3.60 | $540 |
| 82570 Clinical Chemistry | 147 | 65 | $5.08 | $747 |
| 83735 Clinical Chemistry | 85 | 47 | $6.57 | $558 |
| 82652 Clinical Chemistry | 79 | 45 | $37.29 | $2,946 |
| 83540 Clinical Chemistry | 47 | 27 | $6.34 | $298 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohammed A Sikder prescribed most often to Medicare patients was Allopurinol, with 883 prescriptions and refills. In total Mohammed A Sikder wrote 4,907 Medicare prescriptions that cost $557K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Allopurinol Generic | 883 | 2,105 | 223 | $6,236 |
| Calcitriol Generic | 840 | 1,842 | 195 | $13K |
| Losartan Potassium Generic | 329 | 868 | 86 | $2,684 |
| Amlodipine Besylate Generic | 299 | 759 | 77 | $1,472 |
| Farxiga Dapagliflozin Propanediol | 275 | 434 | 51 | $244K |
| Jardiance Empagliflozin | 220 | 310 | 44 | $179K |
| Lisinopril Generic | 131 | 323 | 36 | $627 |
| Furosemide Generic | 105 | 227 | 32 | $308 |
| Metoprolol Succinate Generic | 103 | 283 | 30 | $627 |
| Famotidine Generic | 94 | 192 | 19 | $1,623 |
| Carvedilol Generic | 85 | 198 | 22 | $777 |
| Spironolactone Generic | 78 | 196 | 23 | $720 |
| Metformin Hcl Generic | 78 | 207 | 25 | $548 |
| Cinacalcet Hcl Generic | 75 | 166 | 17 | $15K |
| Ezetimibe Generic | 63 | 108 | 12 | $1,190 |
Brand drugs: 653 claims; generic drugs: 4,254 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammed A Sikder $496 ($496 in general payments such as food, travel and fees) from 12 companies. The largest payer was Vantive US Healthcare LLC with $149.
| Company | Payments | Amount |
|---|---|---|
| Vantive US Healthcare LLC | 1 | $149 |
| Amgen Inc. AMGN | 5 | $80.66 |
| Daiichi Sankyo Inc. 4568.T | 2 | $59.49 |
| Calliditas Therapeutics US Inc. | 1 | $34.33 |
| Ardelyx, Inc. ARDX | 1 | $28.26 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $26.9 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $23.82 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $22.64 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $20.81 |
| Akebia Therapeutics Inc AKBA | 1 | $19.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.